Pharma Perspectives
Perspectives that Sharpen Strategy and Execution
Insights, analysis, and perspectives on how pharma teams can move faster without losing alignment.
Perspectives Bring Together
Commercial and competitive intelligence- Launch, access and lifecycle perspectives
- Agentic AI in regulated environnments
- Decision and execution design for pharma
Featured Items
Stop Blaming AI for Pharma’s Commercial Flops. The Real Culprit? Decisions.
February 3, 2026
Founder perspective on why most AI initiatives in pharma stall not at analytics, but at the decision layer — and what needs to change for AI to scale responsibly. Every week there’s another headline about AI “revolutionizing” pharma — or just as often, about why it’s falling flat. After years in the trenches, one conclusion is clear: AI itself isn’t the problem. The way decisions are made is.
Agentic AI Is Finally Fixing Pharma’s Biggest Self-Inflicted Wound: Silos
January 20, 2026
Why agentic systems — not more process or dashboards — are finally enabling true cross-functional alignment in pharma commercialization. Pharma’s biggest enemy isn’t competition or regulation. It’s the silos the industry built itself.
New Book by AXONAL.AI Founder
Launchcode: Pharma, AI and the Next Frontier
The traditional pharma commercial model wasn’t built for speed, complexity, or orchestration. Launchcode introduces a new operating system for the AI era, powered by intelligent agents, not outdated playbooks. Written by AXONAL.AI founder Larry Mickelberg, this book offers the strategic blueprint behind our platform: how intelligent systems can transform targeting, messaging, field support, access, and performance—faster and smarter.
Recent Items
AI Is Flipping Pharma’s Power Script: Why Biotechs Now Have the Momentum Edge
January 16, 2026
How agentic AI is shifting advantage from scale to speed, clarity, and decision quality. For decades, scale has dominated pharma commercialization. Massive teams, massive budgets, and massive infrastructures absorbed complexity and reduced risk.
The Shared Pen: Why Human–AI Collaboration Is Pharma’s Next Advantage
January 13, 2026
Why the future of AI in pharma is augmentation — not automation — and what true collaboration looks like. After more than two decades in pharma commercialization, one pattern is consistent: outcomes improve when smart people work together effectively.
Axonal Recognized by MM+M as an AI Platform Clients Actually Use
December 30, 2025
Industry recognition matters most when it reflects real-world adoption rather than hype. Axonal.AI was recently included in Medical Marketing & Media’s roundup of AI pharma marketing tools that clients say actually work. In a crowded landscape of experimentation and demos, that distinction matters.
From the Pharmacy Counter to AI Innovation: Why Access Still Drives Everything Axonal.AI Does
April 12, 2025
Long before Larry Mickelberg led digital transformation for global pharma teams… He stood behind the counter of a local pharmacy, learning healthcare one interaction at a time. It was there, as a student, that he first saw the difference between a system working—and a system falling short.
Why AI Strategy Fails in Pharma: You are Skipping the Hard Part
March 27, 2025
AI is not being implemented properly. Not because the technology does not work. Not because pharma is behind the curve. But because most organizations are skipping the part that matters most.
Leapfrogging Big Pharma: The AI Advantage for Biotech Innovators
January 13, 2025
Big Pharma’s dominance isn’t untouchable. AI makes mid-stage biotechs the disruptors. Big Pharma may have size, but size breeds inefficiency. AI doesn’t reward bigness; it rewards agility. Here’s how mid-stage biotechs can leverage AI to disrupt an industry dominated by giants: ✅ Outsmarting Scale: Replace sprawling teams with lean, AI-driven strategies. Imagine launching with 80% fewer staff but delivering faster, smarter outcomes.
Traditional vs. AI-Enhanced Time-to-Market: Why Pharma Can’t Afford to Wait
January 7, 2025
In the pharmaceutical industry, time isn’t just money—it’s lives. Bringing new therapies to market faster means addressing unmet patient needs, maximizing patent value, and staying ahead of competitors. Yet, the traditional commercialization process is riddled with inefficiencies: manual compliance workflows, siloed data, and slow decision-making can stretch timelines to 24 months or more. What if there was a bettter way?
The Pharmaceutical Industry's Quest for Agility: How AI Can Lead the Way
December 30, 2024
The pharmaceutical industry is facing unprecedented challenges—fierce competition, stricter regulations, and increasing demands for innovation. Traditional models are no longer sustainable. AI is emerging as a transformative force, enabling leaner, more agile operations by streamlining processes, fostering data-driven decision-making, and enhancing customer and HCP engagement. Companies that embrace AI can unlock a competitive advantage, while those that delay risk being left behind. Adapting to a New Reality
Generative AI vs. Agentic AI: What’s the Difference and Why Does It Matter for Pharma Commercial Teams?
December 19, 2024
Pharma commercial teams are diving into the world of AI, but not all AI is the same. Two transformative types — Generative AI and Agentic AI — are driving change in unique ways. So, how do they compare, and why do they matter for your sales and marketing strategy? Generative AI: The Creator.
Bringing New Drugs to Market: How AI is Empowering Pharmaceutical Commercial Teams
December 17, 2024
AI is revolutionizing pharmaceutical commercialization, enabling faster, smarter, and more effective drug launches. From uncovering deep market insights and refining messaging to personalizing patient experiences and streamlining compliance, AI empowers commercial teams to execute go-to-market strategies with precision. Despite challenges like regulatory compliance and cultural shifts, the benefits—improved ROI, enhanced HCP engagement, and accelerated launches—are transformative. 👉 Don’t just adapt—lead. Discover how AI can transform your go-to-market strategies. Schedule a demo with Axonal.ai today.
Revolutionizing Medical Affairs: How AI is Transforming Pharma's Bridge to Healthcare
December 10, 2024
AI is transforming Medical Affairs by automating data management, enhancing communication, and driving innovation. These advancements empower Medical Affairs teams to deliver more impactful scientific exchange, improve training, and ultimately enhance patient outcomes while maintaining compliance and trust. The Role of Medical Affairs is More Critical Than Ever
Revolutionizing Pharma Marketing and Sales with Agentic RAG
December 3, 2024
Agentic RAG is revolutionizing pharmaceutical marketing and sales by combining data retrieval and AI-driven content generation. This transformative technology enhances personalization, streamlines operations, drives real-time decisions, enables multichannel engagement, and ensures compliance—all while delivering better outcomes for stakeholders and patients alike. A New Era Has Begun
The Transformative Power of AI in Pharma: Unlocking ROI for Commercial Teams
November 26, 2024
AI is revolutionizing pharma by accelerating market delivery, improving operational efficiency, and enabling personalized engagement strategies. With a strategic approach, commercial teams can achieve impressive ROI and set new standards for industry success. A Seismic Shift is Underway
AI Independence: How Mid-Stage Biotech's Can Leapfrog Big Pharma
November 21, 2024
AI is empowering mid-size biotechs to leapfrog Big Pharma by reducing commercial timelines, slashing costs, and enabling leaner, more agile teams. With AI, marketing leaders can deliver personalized campaigns at scale while maintaining compliance and adapting quickly to market changes. AI is Reshaping Commercial Operations